Commission Implementing Regulation (EU) 2025/1489 of 24 July 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances ametoctradin, Beauveria bassiana strains ATCC 74040 and GHA, buprofezin, clodinafop, copper compounds, cyflumetofen, daminozide, flupyradifurone, Helicoverpa armigera nucleopolyhedrovirus, mandestrobin, mandipropamid, metam, pyraclostrobin, rescalure, Spodoptera littoralis nucleopolyhedrovirus, Streptomyces lydicus strain WYEC 108, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
080/2026
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2025/1489 of 24 July 2025 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances ametoctradin, Beauveria bassiana strains ATCC 74040 and GHA, buprofezin, clodinafop, copper compounds, cyflumetofen, daminozide, flupyradifurone, Helicoverpa armigera nucleopolyhedrovirus, mandestrobin, mandipropamid, metam, pyraclostrobin, rescalure, Spodoptera littoralis nucleopolyhedrovirus, Streptomyces lydicus strain WYEC 108, Trichoderma asperellum strain T34 and Trichoderma atroviride strain I-1237
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2025/1489 frá 24. júlí 2025 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilunum fyrir virku efnin ametóktradín, Beauveria bassiana af stofnum ATCC 74040 og GHA, búprófesín, klódínafóp, koparefnasambönd, sýflúmetófen, damínósíð, flúpýradífúrón, Helicoverpa armigera-kjarnmargflötungaveiru, mandestróbín, mandíprópamíð, metam, pýraklóstróbín, reskalúr, Spodoptera littoralis-kjarnmargflötungaveiru, Streptomyces lydicus af stofni WYEC 108, Trichoderma asperellum af stofni T34 og Trichoderma atroviride af stofni I-1237
Durchführungsverordnung (EU) 2025/1489 der Kommission vom 24. Juli 2025 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Laufzeit der Genehmigungen für die Wirkstoffe Ametoctradin, Beauveria bassiana Stämme ATCC 74040 und GHA, Buprofezin, Clodinafop, Kupferverbindungen, Cyflumetofen, Daminozid, Flupyradifuron, Helicoverpa armigera Nucleopolyhedrovirus, Mandestrobin, Mandipropamid, Metam, Pyraclostrobin, Rescalure, Spodoptera littoralis Nucleopolyhedrovirus, Streptomyces lydicus Stamm WYEC 108, Trichoderma asperellum Stamm T34 und Trichoderma atroviride Stamm I-1237
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.